[ENT manifestations of myeloid sarcoma].

Autor:	Belaidi DS; Service d'ORL et de chirurgie cervicofaciale, Centre hospitalier universitaire vaudois, 1011 Lausanne., George M; Service d'ORL et de chirurgie cervicofaciale, Centre hospitalier universitaire vaudois, 1011 Lausanne., Ceppi F; Unité d'hématologie-oncologie, Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne., Gengler C; Service de pathologie clinique, Département médecine de laboratoire et pathologie, Centre hospitalier universitaire vaudois, 1011 Lausanne., Schurmann G; Service d'ORL et de chirurgie cervicofaciale, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Jazyk:	francouzština
Zdroj:	Revue medicale suisse [Rev Med Suisse] 2024 Oct 02; Vol. 20 (889), pp. 1761-1764.
DOI:	10.53738/REVMED.2024.20.889.1761
Abstrakt:	Myeloid sarcoma (MS) is a rare extra-medullary manifestation of acute myeloid leukaemia (AML) in the form of a first manifestation, progression or recurrence. Mostly located in the bones, it has the particularity of reaching the ENT sphere by mimicking common patho-logies, leading to a delay in diagnosis and treatment. The -mastoid involvement that we have encountered in our clinical -practice (clinical vignette) shows the complexity of identifying this pathology, with very few cases reported in the literature. The anamnesis, including a -history of AML, and the clinical examination help to guide the investigations. Targeted imaging, in this case CT/MRI combined with a biopsy of the lesion and a marrow puncture, is used to make the -diagnosis. Treatment with chemotherapy is indicated and rapidly initiated. Competing Interests: Les auteur-es n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu